Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – As in adult diabetics, hemoglobin (Hb) A1c levels are higher in black children with type 1 disease than in white children, independent of…
Micheal Swiernik, MD, Director, Medical Informatics, UCLA, discusses the considerations before purchasing an EMR that suits your workplace, and the costs associated with implementing this into your practice…
Gary Small, MD, Director, UCLA Center on Aging, UCLA, discusses his new book, ibrain, and talks about the younger digital generation who do not have the face-to-face communication…
Richard J Shemin, MD, Chief of Cardiothoracic Surgery, UCLA David Geffen School of Medicine, discusses hybrid approaches to cardiology and cardiothoracic surgery, such as operation rooms where interventional…
Arya Nick Shamie, MD, Associate Professor of Orthopedic Surgery and Neurosurgery, UCLA David Geffen School of Medicine, discusses the use of stem cells in spinal surgery to grow…
Reza Jarrahy MD, Assistant Professor, David Geffen School of Medicine at UCLA, Division of Plastic and Reconstructive Surgery, discusses how to evaluate neonates with micrognathia and avoid tracheostomy.…
David Heber, MD, Professor of Medicine, Director, UCLA Center for Human Nutrition, discusses prostate cancer prevention, and explains why low fat diets and exercise can reduce inflammation by…
Joseph Demer, MD, Professor of Opthalmology and Neurology, UCLA David Geffen School of Medicine, discusses strabismus and describes mechanical causes versus neurological causes of this eye condition. If…
Andrew Charles, MD, Professor, Director of Headache Research and Treatment Program, UCLA David Geffen School of Medicine, discusses when to get a scan for a headache and the…
NEW YORK (Reuters Health) – Ethosuximide and valproic acid are more effective than lamotrigine for treating childhood absence epilepsy, the most common pediatric epilepsy syndrome, according to a…
